Actually, carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCCA), and CYFRA21-1 were the most widely used serum biomarkers for ESCC, but the performance of these biomarkers to detect early-stage ESCC is deficient [6–8]. The gene discussed is CEACAM5; the disease is esophageal squamous cell carcinoma.